Details for Patent: 9,539,258
✉ Email this page to a colleague
Which drugs does patent 9,539,258 protect, and when does it expire?
Patent 9,539,258 protects GILOTRIF and is included in one NDA.
Protection for GILOTRIF has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has ten patent family members in four countries.
Summary for Patent: 9,539,258
| Title: | Quinazoline derivatives for the treatment of cancer diseases |
| Abstract: | The present invention relates to the use of quinazolines of formula (I), ##STR00001## wherein the groups R.sup.a to R.sup.d have the meanings given in the claims and specification, in cancer therapy. |
| Inventor(s): | Solca; Flavio (Vienna, AT), Amelsberg; Andree (Southbury, CT), van Meel; Jacobus C. A. (Moedling, AT), Baum; Anke (Moedling, AT), Stehle; Gerd (Ehingen, DE) |
| Assignee: | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) |
| Application Number: | 14/739,299 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,539,258 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,539,258
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | GILOTRIF | afatinib dimaleate | TABLET;ORAL | 201292-001 | Jul 12, 2013 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Boehringer Ingelheim | GILOTRIF | afatinib dimaleate | TABLET;ORAL | 201292-002 | Jul 12, 2013 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Boehringer Ingelheim | GILOTRIF | afatinib dimaleate | TABLET;ORAL | 201292-003 | Jul 12, 2013 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,539,258
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 05110656 | Nov 11, 2005 | |
International Family Members for US Patent 9,539,258
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2629244 | ⤷ Sign Up | |||
| Canada | 2833706 | ⤷ Sign Up | |||
| Canada | 2833852 | ⤷ Sign Up | |||
| European Patent Office | 1948179 | ⤷ Sign Up | |||
| European Patent Office | 3173084 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
